Role of adjuvant chemotherapy in patients with early stage uterine papillary serous cancer

International Journal of Gynecological Cancer

Volumn 21, Issue 8, 2011, Pages 1436-1440

  Mahdavi, Ali ^a,b   Tajalli, Tania R ^c   Dalmar, Ahmed ^b   Vasilev, Steven A ^c   Lentz, Scott E ^c   Berman, Michael L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AURORA HEALTH CARE   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

Adjuvant chemotherapy; Uterine papillary serous carcinoma

Indexed keywords

PLATINUM; ANTINEOPLASTIC AGENT; CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; UTERINE PAPILLARY SEROUS CANCER; UTERUS CANCER; ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; CYSTADENOCARCINOMA; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; TUMOR RECURRENCE; UNITED STATES;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CALIFORNIA; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, PAPILLARY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; RETROSPECTIVE STUDIES; UTERINE NEOPLASMS;

EID: 84857485703     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31822e7588     Document Type: Article

References (14)

1. Hamilton CA, Cheung MK, Osann K, et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer. 2006;94:642-646. (Pubitemid 43361894)
2. Fader AN, Drake RD, O'Malley DM, et al. Platinum/taxaneYbased chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer. 2009;15:2119-2127.
3. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009;105:109.
4. Hendrickson M, Ross J, Eifel P, et al. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 1982;6:93-108. (Pubitemid 12108965)
5. Chan JK, Loizzi V, Youssef M, et al. Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol Oncol. 2003;90:181-185. (Pubitemid 37338095)
6. Christman JE, Kapp DS, Hendrickson MR, et al. Therapeutic approaches to uterine papillary serous carcinoma: a preliminary report. Gynecol Oncol. 1987;26:228-235. (Pubitemid 17026683)
7. Huh WK, Powell M, Leath CA 3rd, et al. Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy. Gynecol Oncol. 2003;91:470-475. (Pubitemid 38388138)
8. Dietrich CS 3rd, Modesitt SC, DePriest PD, et al. The efficacy of adjuvant platinum-based chemotherapy in stage I uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 2005;99:557-563. (Pubitemid 41686536)
9. Havrilesky LJ, Secord AA, Bae-Jump V, et al. Outcomes in surgical stage I uterine papillary serous carcinoma. Gynecol Oncol. 2007;105:677-682. (Pubitemid 46734192)
10. Fader AN, Nagel C, Axtell AE, et al. Stage II uterine papillary serous carcinoma: carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes. Gynecol Oncol. 2009;112:558-562.
11. Kelly MG, O'malley DM, Hui P, et al. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol. 2005;98:353-359.
12. Hamilton CA, Liou WS, Osann K, et al. Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys. 2005;63:839-844. (Pubitemid 41400073)
13. Zanotti KM, Belinson JL, Kennedy AW, et al. The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma. Gynecol Oncol. 1999;74:272-277. (Pubitemid 29377225)
14. Lewin SN, Herzog TJ, Barrena Medel NI, et al. Comparative performance of the 2009 International Federation of Gynecology and Obstetrics' staging system for uterine corpus cancer. Obstet Gynecol. 2010;116:1141-1149.